Efficacy and Safety of Zhenyuan Capsule for Coronary Heart Disease with Abnormal Glucose and Lipid Metabolism: Study Protocol for a Randomized, Double-Blind, Parallel-Controlled, Multicenter Clinical Trial
Background. Coronary heart disease (CHD) and abnormal glucose and lipid metabolism are closely associated and generally coexist. The Qi and Yin deficiency syndrome is a common disease pattern encountered in traditional Chinese medicine. We designed a protocol to determine the effectiveness and safet...
Main Authors: | Yu Qiao, Jingchun Zhang, Yue Liu, Zhiqi Liang, Yuhua Wang, Wei Zheng, Dazhuo Shi |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2018/1716430 |
Similar Items
-
Alteration and mineralization styles of the orogenic disseminated Zhenyuan gold deposit, southeastern Tibet: Contrast with carlin gold deposit
by: Huajian Li, et al.
Published: (2019-09-01) -
A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Study of the Effects of Tongxinluo Capsules in Acute Coronary Syndrome Patients with High On-Treatment Platelet Reactivity
by: Lei Zhang, et al.
Published: (2018-01-01) -
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Duliang Soft Capsule in Patients with Chronic Daily Headache
by: Shengyuan Yu, et al.
Published: (2015-01-01) -
Treatment of Common Cold Patients with the Shi-Cha Capsule: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial
by: Jing Chang, et al.
Published: (2012-01-01) -
Bufei huoxue capsules in the management of convalescent COVID-19 infection: study protocol for a multicenter, double-blind, and randomized controlled trial
by: Yuqin Chen, et al.
Published: (2021-08-01)